161
Views
7
CrossRef citations to date
0
Altmetric
Original

Liposomal encapsulated doxorubicin (Caelyx) in the treatment of relapsed aggressive non-Hodgkin's lymphoma: A phase II study

, , , , &
Pages 1327-1332 | Received 06 Jul 2005, Accepted 09 Nov 2005, Published online: 01 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Eileen Mary Boyle & Franck Morschhauser. (2015) Pixantrone: a novel anthracycline-like drug for the treatment of non-Hodgkin lymphoma. Expert Opinion on Drug Safety 14:4, pages 601-607.
Read now
Dionysios Papadatos-Pastos & Ruth Pettengell. (2013) Pixantrone: merging safety with efficacy. Expert Review of Hematology 6:1, pages 25-33.
Read now
Mariam Jamal-Hanjani & Ruth Pettengell. (2011) Pharmacokinetic evaluation of pixantrone for the treatment of non-Hodgkin's lymphoma. Expert Opinion on Drug Metabolism & Toxicology 7:11, pages 1441-1448.
Read now
Deborah Mukherji & Ruth Pettengell. (2010) Pixantrone for the treatment of aggressive non-Hodgkin lymphoma. Expert Opinion on Pharmacotherapy 11:11, pages 1915-1923.
Read now

Articles from other publishers (3)

Ann Colosia, Annete Njue, Peter C. Trask, Robert Olivares, Shahnaz Khan, Adeline Abbe, Rachel Police, Jianmin Wang, Rodrigo Ruiz-Soto, James A. Kaye & Farrukh Awan. (2014) Clinical Efficacy and Safety in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A Systematic Literature Review. Clinical Lymphoma Myeloma and Leukemia 14:5, pages 343-355.e6.
Crossref
Bo Guo, Hong-Li Zhu, Su-Xia Li, Xue-Chun Lu & Hui Fan. (2011) Individualized Liposomal Doxorubicin-Based Treatment in Elderly Patients with Non-Hodgkin’s Lymphoma. Onkologie 34:4, pages 184-188.
Crossref
. (2007) Current Awareness in Hematological Oncology. Hematological Oncology 25:2, pages 98-105.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.